ARCHIVES

Childhood Cancer Survivors Do Not Have an Increased Risk Of Passing On Birth Defects

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Radium Society To Meet In L.A.

March 2, 1979

Kimes Heads NCI Organ Systems Committee; Changes Being Implemented

April 1, 1988

NCI Advisors To Evaluate SPORE Program; Large Grants to Be Weighed Against R01s

December 12, 1997

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

Cancer Information Available By Fax

May 3, 1991